» Articles » PMID: 36600467

Utilisation, Effectiveness, and Safety of Immediate Postpartum Intrauterine Device Insertion: a Systematic Literature Review

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Intrauterine devices (IUDs) are highly effective contraception. IUDs inserted directly following delivery provide immediate birth control and may decrease unintended pregnancies, including short-interval pregnancies, thereby mitigating health risks and associated economic burden.

Methods: This systematic literature review included published global data on the utilisation, effectiveness, and safety of postpartum intrauterine devices (PPIUDs) of any type. English language articles indexed in MEDLINE, Embase, and Cochrane from January 2010-October 2021 were included.

Results: 133 articles met the inclusion criteria (46% interventional studies; 54% observational; n=87 from lower-income countries; n=46 from higher-income countries). PPIUD use was low in higher-income countries (6/10 000 US deliveries in 2013-2016) and varied widely in lower-income countries (2%-46%). Across both higher- and lower-income countries, in most studies (79%), >80% of women with PPIUDs had an IUD in place by 3 months; at 6 and 12 months, 76% and 54% of included studies reported that >80% of women had an IUD in place; reason for discontinuation was infrequently reported. Pregnancies were rare (96 pregnancies across 12 191 women from 37 studies reporting data) and were generally unrelated to device failure, but rather occurred in women no longer using a PPIUD. Expulsions occurred mainly in the early outpatient period and ranged widely (within 3 months: 0-41%). Abnormal bleeding, infections, or perforations were rare.

Conclusions: PPIUDs are safe and effective. Long-term follow-up data are limited. Future research elucidating reasons underlying lack of PPIUD use is warranted.

Citing Articles

Follow-up of immediate postpartum intrauterine device insertion: a scoping review protocol.

Herculano T, Amaral-Moreira C, Bennini Junior J, Surita F BMJ Open. 2025; 14(12):e092783.

PMID: 39806629 PMC: 11667373. DOI: 10.1136/bmjopen-2024-092783.


Expanding access to postpartum contraception.

Cooper M, Black K, Cameron S Curr Opin Obstet Gynecol. 2024; 36(5):331-337.

PMID: 39109628 PMC: 11361352. DOI: 10.1097/GCO.0000000000000982.

References
1.
Lester F, Kakaire O, Byamugisha J, Averbach S, Fortin J, Maurer R . Intracesarean insertion of the Copper T380A versus 6 weeks postcesarean: a randomized clinical trial. Contraception. 2014; 91(3):198-203. DOI: 10.1016/j.contraception.2014.12.002. View

2.
Turok D, Leeman L, Sanders J, Thaxton L, Eggebroten J, Yonke N . Immediate postpartum levonorgestrel intrauterine device insertion and breast-feeding outcomes: a noninferiority randomized controlled trial. Am J Obstet Gynecol. 2017; 217(6):665.e1-665.e8. PMC: 6040814. DOI: 10.1016/j.ajog.2017.08.003. View

3.
Hooda R, Mann S, Nanda S, Gupta A, More H, Bhutani J . Immediate Postpartum Intrauterine Contraceptive Device Insertions in Caesarean and Vaginal Deliveries: A Comparative Study of Follow-Up Outcomes. Int J Reprod Med. 2016; 2016:7695847. PMC: 5005603. DOI: 10.1155/2016/7695847. View

4.
Weerasekera D, Senanayeke L, Ratnasiri P, Perera G, Lanerolle S, Godakandage S . Four years of the FIGO postpartum intrauterine device initiative in Sri Lanka: Pilot initiative to national policy. Int J Gynaecol Obstet. 2018; 143 Suppl 1:28-32. DOI: 10.1002/ijgo.12601. View

5.
Zaconeta A, Oliveira A, Estrela F, Vasconcelos T, Franca P, da Silva Wanderley M . Intrauterine Device Insertion during Cesarean Section in Women without Prenatal Contraception Counseling: Lessons from a Country with High Cesarean Rates. Rev Bras Ginecol Obstet. 2019; 41(8):485-492. PMC: 10316793. DOI: 10.1055/s-0039-1693677. View